cawd-176,欧美 性爱 国产 综合,亚洲国产黄色在线,庆余年在线观看免费
中文簡(jiǎn)體
中文簡(jiǎn)體
English
HOME
ABOUT US
Company Profile
Company Culture
Company Honor
R&D
Technology Platform
Pipelines
NEWS
Press Release
Awards
CAREERS
CONTACT US
中文簡(jiǎn)體
中文簡(jiǎn)體
English
Search
/uploads/image/img/banner-txt-en-03.svg
首頁(yè)
-
NEWS
-
Press Release
Press Release
Awards
Press Release
Awards
貝海生物用于治療非肌層浸潤(rùn)性膀胱癌BH011新藥項(xiàng)目II期臨床研究完成首例患者給藥
2023-03-06
貝海生物創(chuàng)新藥物BH009用于治療晚期三陰性乳腺癌的II期臨床試驗(yàn)申請(qǐng)獲CDE受理
2023-01-31
重磅新藥出海在即!貝海生物BH009順利完成美國(guó)FDA pre-NDA會(huì)議
2022-12-05
貝海生物BH009新藥項(xiàng)目新適應(yīng)癥獲CDE批準(zhǔn)開展臨床
2022-11-24
貝海生物完成近2億元B輪融資,持續(xù)聚焦差異化腫瘤創(chuàng)新產(chǎn)品
2022-11-01
貝海生物BH009新藥項(xiàng)目新適應(yīng)癥臨床試驗(yàn)申請(qǐng)獲CDE受理
2022-09-19
貝海生物止吐新藥BH006獲CDE批準(zhǔn)開展臨床
2022-06-13
貝海生物BH011 新藥項(xiàng)目新適應(yīng)癥II期臨床獲批
2022-04-18
<<
1
2
3
4
>>
ABOUT US
R&D
NEWS
CAREERS
CONTACT US
Contact Information
Company address:Blg 2, No. 6366, Zhuhai Ave., Jinwan, Zhuhai, 519090, China
Tel:0756-6349669
Human resources contact:hr@bayhibiotech.com
Business cooperation contact:hjiang@bayhibiotech.com
Wechat Official Account
Copyright ? 2023 Zhuhai Beihai Biotech Co., Ltd.
Copyright Registration No. :
Guangdong ICP for 17134092
Technical support :
Xiangxun Technology